Benítez NPP, Gutiérrez PM, Torriente OD, Mesa GM

Language: Spanish
References: 28
Page:
PDF size: 368.47 Kb.

ABSTRACT

Introduction. In order to evaluate the efficacy of intradiscal platelet rich plasma application as a treatment for discogenic lumbar pain, a double-blind therapeutic clinical trial was conducted. Methods. The patients were randomly assigned to two study groups. Group A was given intradiscal platelet rich plasma and B intradiscal ozone. Both procedures were performed under local anesthesia, under fluoroscopic control. To assess clinical improvement, the visual analogue scale and the Latinen test were taken into account. To identify the radiological improvement, it was determined if there had been an increase in the intervertebral disc height greater than 50% or if there was improvement in the classification of Pfirman. In addition, the adverse events that occurred in both groups were determined. Results. The intradiscal platelet rich plasma group obtained a greater number of patients with clinical and radiological improvement, with statistical significance, and fewer adverse events (p <0.001). Conclusions. Intradiscal platelet rich plasma administration was a more effective procedure than intradiscal ozone therapy to relieve discogenic lumbar pain.

REFERENCES

1. Pennicooke B, Moriguchi Y, Hussain I, et al. (November 22, 2016) Biological Treatment Approaches for Degenerative Disc Disease: A Review of Clinical Trials and Future Directions. Cureus 8(11): e892. DOI 10.7759/cureus.892.

2. Vadalà G, Russo F., Martino A. D., Vincenzo D. Intervertebral disc regeneration: from the degenerative cascade to molecular therapy and tissue engineering Tissue Eng. Regen Med 2015; 9: 679–690.

3. 3 Michael J., DE Palma, Ketchum J. M, and Saullo P. What Is the Source of Chronic Low Back Pain and Does Age Play a Role? pme_ Pain Medicine 2011; 12: 224–233.

4. 4 Fuji K., et al. Discogenic back pain: literature review of definition, diagnosis, and treatment. Journal of Bone and Mineral Research Initial Date Submitted April 19, 2018; Date Revision Submitted January 9, 2019; Date Final Disposition Set January 30, 2019 doi: [10.1002/jbm4.10180]

5. 5 Ohtori S, Inoue G, Miyagi M, Takahashi K. Pathomechanisms of discogenic low back pain in humans and animal models. Spine J. 2015;15(6):1347–55.

6. Ito K, Creemers L. Mechanisms of Intervertebral Disk Degeneration/Injury and Pain: A Review. Global Spine J. 2013;3(3):145–51.

7. Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44-56.

8. on ZI, Doolittle AC, Snuggs JW, Shapiro IM, Le Maitre CL, Risbud MV. TNF-α promotes nuclear enrichment of the transcription factor Ton EBP/NFAT5 to selectively control inflammatory but not osmoregulatory responses in nucleus pulposus cells. J Biol Chem. 2017;292(42):17561-17575.

9. Malik KM, Cohen SP, Walega DR, Benzon HT. Diagnostic criteria and treatment of discogenic pain: a systematic review of recent clinical literature. Spine J. 2013;13(11):1675–89.

10. 10.Nijs J, Clark J, Malfliet A, Ickmans K, Voogt L, Don S, et al. In the spine or in the brain? Recent advances in pain neuroscience applied in the intervention for low back pain. Clin Exp Rheumatol.2017;35 Suppl 107(5):108–15.

11. Raastad J, Reiman M, Coeytaux R, Ledbetter L, Goode AP. The association between lumbar spine radiographic features and low back pain: a systematic review and meta-analysis. Semin Arthritis Rheum. 2015;44(5):571–85.

12. Teraguchi M, Samartzis D, Hashizume H, Yamada H, Muraki S, Oka H, et al. Classification of High Intensity Zones of the Lumbar Spine and Their Association with Other Spinal MRI Phenotypes: The Wakayama Spine Study. PLoS ONE. 2016;11(9): e0160111–6.

13. 13.Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356-2367.

14. Guyer RD, Ohnmeiss DD, NASS. Lumbar discography. The Spine Journal. 2003;3(3 Suppl):11S–27S.

15. Carragee EJ, Don AS, Hurwitz EL, Cuellar JM, Carrino JA, Carrino J, et al. ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study. Spine. 2009;34(21):2338–45.

16. Rizvi M.R. Novel treatment strategies for intervertebral disc degeneration. Saudi Journal for Health Sciences - Vol 4, Issue 1, Jan-Apr 2015 345-352.

17. Akeda K, Ohishi K, Masuda K, Bae WC, Takegami N, Yamada J, Nakamura T, Sakakibara T, Kasai Y, Sudo A (2017) Intradiscal injection of autologous platelet-rich plasma Release to treat Discogenic low back pain: a preliminary clinical trial. Asian Spine journal 11(3):380–389. doi:10.4184/asj. 2017.11.3.380

18. Anitua E, Sanchez M, Aguirre JJ, Prado R, Padilla S, Orive G (2014) Efficacy and safety of plasma rich in growth factors intra-articular infiltrations in the treatment of knee osteoarthritis. Arthroscopy: the journal of arthroscopic & related surgery: official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 30 (8):1006–1017. doi: 10.1016/j.arthro.2014.05.021

19. Bhatia R, Chopra G (2016) Efficacy of Platelet Rich Plasma via Lumbar Epidural Route in Chronic Prolapsed Intervertebral Disc Patients-A Pilot Study. Journal of clinical and diagnostic research: JCDR 10 (9): Uc05-uc07. doi:10.7860/jcdr/ 2016/21863.8482.

20. Benítez Núñez P.P., González Guerra Y., Álvarez Monteagudo C. Valor diagnóstico de la discografía con ozono, en el dolor radicular provocado por hernias discales lumbares. Invest Medicoquir. 2014(enero-junio);6(1):36-46. ISSN: 1995-9427, RNPS: 2162

21. Benítez Núñez P.P y colaboradores. Eficacia del Azul de Metileno Intradiscal como tratamiento del dolor discogénico lumbar. Invest Medicoquir.2019 ISSN: 1995-9427, RNPS: 2162

22. Yang The H. Et al. Role of TGF-b1/Smad2/3 pathway in platelet-rich plasma in retarding intervertebral disc degeneration J. Cell. Mol. Med. Vol. 20, No 8, 2016 pp. 1542-1549.

23. Llano Conrado H., Hernández Santos J. R, Tenopala Villegas Canseco Aguilar, C. P. y Torres Huerta J. C. Efecto del plasma rico en plaquetas y/o factores de crecimiento sobre la regeneración y el dolor crónico asociado a discopatía intervertebral. Revisión sistemática. Rev. Soc. Esp. Dolor 2016; 23(3): 145-153

24. Schwartz, A. Martínez- Sánchez, G. Re, L. (2011). Factores de crecimiento derivados de plaquetas y sus aplicaciones en medicina regenerativa. Potencialidades del uso del ozono como activador. Revista Española de Ozonoterapia. Vol.1, nº 1, pp. 54-73.

25. Zhang R, Ruan D, Zhang C. Effects of TGF-β1 and IGF-1 on proliferation of human nucleus pulposus cells in medium with different serum concentrations. J Orthop Surg 2006; 1:9.

26. 26 Kim et al. Anti-Inflammatory Effect of Platelet-Rich Plasma on Nucleus Pulposus Cells with Response of TNF-a and IL-1. Journal of Orthopedic Research April 2014 DOI 10.1002/jor.22532

27. Nagae M, Ikeda T, Mikami Y. Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng: 2007; 13:147–158.

28. Gullung GB, Woodall JW, Tucci MA, et al (2011) Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid Based Spine Care J 2:13 –18.